The Coronavirus is continuing its spread around the world with all kind of measures as consequence. Recently it was decided in Europe to begin with easening the lock down measures. Based on the current measures the Central Committee on Research Involving Human Subjects (CCMO), Health and Youth Care Inspectorate (IGJ) and European Medicines Agency (EMA) have updated their COVID-19 guidelines.
For an overview of all guidelines see below an overview of the links with the most recent information about guidance on the management of clinical trials during the Coronavirus pandemic:
